News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
376,374 Results
Type
Article (14745)
Company Profile (115)
Press Release (361509)
Multimedia
Podcasts (50)
Webinars (9)
Section
Business (112815)
Career Advice (457)
Deals (18657)
Drug Delivery (41)
Drug Development (31258)
Employer Resources (51)
FDA (8837)
Job Trends (7696)
News (173078)
Policy (12405)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Standard (3)
Academia (1334)
Accelerated approval (10)
Allergies (71)
Alliances (34937)
ALS (42)
Alzheimer's disease (628)
Antibody-drug conjugate (ADC) (179)
Approvals (9041)
Artificial intelligence (444)
Autoimmune disease (61)
Automation (31)
Bankruptcy (131)
Best Places to Work (6520)
BIOSECURE Act (7)
Biosimilars (31)
Biotechnology (85)
Bladder cancer (62)
Brain cancer (27)
Breast cancer (262)
Cancer (2189)
Cardiovascular disease (149)
Career advice (416)
Career pathing (9)
CAR-T (200)
CDC (8)
Cell therapy (489)
Cervical cancer (21)
Clinical research (25870)
Collaboration (1231)
Compensation (230)
Complete response letters (8)
COVID-19 (1223)
CRISPR (85)
C-suite (481)
Cystic fibrosis (60)
Data (2637)
Decentralized trials (1)
Denatured (26)
Depression (43)
Diabetes (211)
Diagnostics (5146)
Digital health (36)
Diversity (7)
Diversity, equity & inclusion (9)
Drug discovery (163)
Drug pricing (19)
Drug shortages (4)
Duchenne muscular dystrophy (86)
Earnings (40543)
Editorial (9)
Employer branding (8)
Employer resources (45)
Events (53437)
Executive appointments (549)
FDA (10441)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (5)
Frontotemporal dementia (8)
Funding (898)
Gene editing (171)
Generative AI (38)
Gene therapy (345)
GLP-1 (303)
Government (1278)
Grass and pollen (3)
Guidances (220)
Healthcare (9919)
HIV (23)
Huntington's disease (13)
IgA nephropathy (26)
Immunology and inflammation (68)
Immuno-oncology (19)
Indications (50)
Infectious disease (1364)
Inflammatory bowel disease (81)
Inflation Reduction Act (5)
Influenza (73)
Intellectual property (151)
Interviews (52)
IPO (8061)
IRA (10)
Job creations (1438)
Job search strategy (363)
JPM (20)
Kidney cancer (6)
Labor market (24)
Layoffs (131)
Leadership (7)
Legal (2536)
Liver cancer (43)
Longevity (6)
Lung cancer (245)
Lymphoma (171)
Machine learning (34)
Management (18)
Manufacturing (524)
MASH (36)
Medical device (11842)
Medtech (11891)
Mergers & acquisitions (11230)
Metabolic disorders (400)
Multiple sclerosis (62)
NASH (3)
Neurodegenerative disease (120)
Neuropsychiatric disorders (19)
Neuroscience (1083)
NextGen: Class of 2026 (3537)
Non-profit (1533)
Now hiring (15)
Obesity (139)
Opinion (97)
Ovarian cancer (92)
Pain (105)
Pancreatic cancer (101)
Parkinson's disease (119)
Partnered (20)
Patents (301)
Patient recruitment (243)
Peanut (31)
People (33684)
Pharmaceutical (18)
Pharmacy benefit managers (3)
Phase 1 (9519)
Phase 2 (11616)
Phase 3 (7552)
Pipeline (2546)
Policy (59)
Postmarket research (502)
Preclinical (4282)
Press Release (66)
Prostate cancer (96)
Psychedelics (6)
Radiopharmaceuticals (177)
Rare diseases (299)
Real estate (3399)
Recruiting (22)
Regulatory (10380)
Reports (20)
Research institute (1300)
Resumes & cover letters (69)
Rett syndrome (21)
RNA editing (9)
RSV (40)
Schizophrenia (32)
Series A (162)
Series B (109)
Service/supplier (6)
Sickle cell disease (32)
Special edition (1)
Spinal muscular atrophy (60)
Sponsored (20)
Startups (2528)
State (2)
Stomach cancer (2)
Supply chain (48)
Tariffs (10)
The Weekly (23)
Vaccines (496)
Venture capital (43)
Weight loss (50)
Women's health (45)
Worklife (2)
Date
Today (3)
Last 7 days (274)
Last 30 days (1110)
Last 365 days (14675)
2026 (1396)
2025 (15032)
2024 (18706)
2023 (22098)
2022 (30813)
2021 (32514)
2020 (30545)
2019 (25809)
2018 (19470)
2017 (18877)
2016 (17761)
2015 (20560)
2014 (15177)
2013 (12743)
2012 (13783)
2011 (14071)
2010 (12831)
Location
Africa (325)
Alabama (69)
Alaska (6)
Arizona (178)
Arkansas (10)
Asia (24893)
Australia (4315)
California (5290)
Canada (1668)
China (547)
Colorado (284)
Connecticut (235)
Delaware (107)
Europe (50937)
Florida (906)
Georgia (219)
Hawaii (2)
Idaho (33)
Illinois (472)
India (33)
Indiana (263)
Iowa (8)
Japan (271)
Kansas (101)
Kentucky (15)
Louisiana (18)
Maine (22)
Maryland (718)
Massachusetts (3540)
Michigan (274)
Minnesota (407)
Mississippi (4)
Missouri (98)
Montana (27)
Nebraska (15)
Nevada (51)
New Hampshire (83)
New Jersey (1561)
New Mexico (18)
New York (1418)
North Carolina (758)
North Dakota (9)
Northern California (2241)
Ohio (169)
Oklahoma (16)
Oregon (24)
Pennsylvania (1010)
Puerto Rico (19)
Rhode Island (34)
South America (512)
South Carolina (60)
South Dakota (1)
Southern California (2267)
Tennessee (103)
Texas (876)
United States (19713)
Utah (193)
Vermont (1)
Virginia (90)
Washington D.C. (18)
Washington State (502)
West Virginia (3)
Wisconsin (87)
Wyoming (1)
376,374 Results for "palatin technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Palatin Technologies Announces Pricing of Upsized $15.8 Million Public Offering
November 7, 2025
·
7 min read
Press Releases
Palatin Technologies Announces Closing of Upsized $18.2 Million Public Offering with the Full Exercise of the Underwriters’ Over-Allotment Option
November 13, 2025
·
6 min read
Press Releases
Rhineland-Palatinate Biotech Company MODAG Receives Research Grant Funding from The Michael J. Fox Foundation
December 18, 2025
·
3 min read
Press Releases
Palatin Presents Data at ObesityWeek® 2025 Highlighting Promise of Melanocortin-Based Therapies for Obesity
November 7, 2025
·
7 min read
Press Releases
Palatin Reports First Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update
November 14, 2025
·
15 min read
Press Releases
Boehringer Ingelheim and Palatin Technologies to develop potential first-in-class melanocortin receptor targeted treatment for patients with retinal diseases
August 19, 2025
·
6 min read
Press Releases
Palatin Technologies Announces Closing of Reduced Public Offering
May 9, 2025
·
5 min read
Press Releases
Palatin Announces 1-for-50 Reverse Stock Split
August 11, 2025
·
3 min read
Press Releases
Palatin Technologies Announces Pricing of up to $23 Million Public Offering
May 7, 2025
·
5 min read
Press Releases
Palatin Earns €5.5 Million ($6.5 Million) Milestone Payment in Retinal Disease Collaboration with Boehringer Ingelheim
September 23, 2025
·
3 min read
1 of 37,638
Next
